 Statera Biopharma Inc NASDAQ: STAB has entered into a non-binding term sheet with Immune Therapeutics Inc OTC: IMUN to sell its naltrexone and met-enkephalin rights. The transaction is contingent upon the negotiation of a definitive agreement and satisfaction of. 